The hypoxia-inducible factors: Key transcriptional regulators of hypoxic responses

Cellular and Molecular Life Sciences

Volumn 60, Issue 7, 2003, Pages 1376-1393

  Bracken, C P ^a   Whitelaw, M L ^a   Peet, D J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

bHLH PAS; Hydroxylation; Hypoxia; Hypoxia inducible factor; Oxygen; Transcription

Indexed keywords

ERYTHROPOIETIN; HELIX LOOP HELIX PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

GENE TARGETING; HUMAN; HYPOXIA; MAMMAL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CELL HYPOXIA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAMMALS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 0042368882     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-2370-y     Document Type: Review

References (260)

1. Semenza G. L. and Wang G. L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12: 5447-5454
2. Wang G. L. and Semenza G. L. (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268: 21513-21518
3. Wang G. L. and Semenza G. L. (1995) Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270: 1230-1237
4. Wang G. L., Jiang B. H., Rue E. A. and Semenza G. L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92: 5510-5514
5. Hoffman E. C., Reyes H., Chu F. F., Sander F., Conley L. H., Brooks B. A. et al. (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252: 954-958
6. Li H., Ko H. P. and Whitlock J. P. (1996) Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha. J. Biol. Chem. 271: 21262-21267
7. Arany Z., Huang L. E., Eckner R., Bhattacharya S., Jiang C., Goldberg M. A. et al. (1996) An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93: 12969-12973
8. Moore A. W., Barbel S., Jan L. Y. and Jan Y. N. (2000) A genomewide survey of basic helix-loop-helix factors in Drosophila. Proc. Natl. Acad. Sci. USA 97: 10436-10441
9. Taylor B. L. and Zhulin I. B. (1999) PAS domains: internal sensors of oxygen, redox potential and light. Microbiol. Mol. Biol. Rev. 63: 479-506
10. Pongratz I., Antonsson C., Whitelaw M. L. and Poellinger L. (1998) Role of the PAS domain in regulation of dimerization and DNA binding specificity of the dioxin receptor. Mol. Cell. Biol. 18: 4079-4088
11. Zelzer E., Wappner P. and Shilo B. Z. (1997) The PAS domain confers target gene specificity of Drosophila bHLH/PAS proteins. Genes Dev. 11: 2079-2089
12. Bacon N. C., Wappner P., O'Rourke J. F., Bartlett S. M., Shilo B., Pugh C. W. et al. (1998) Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: functional evidence for homology with mammalian HIF-1 alpha. Biochem. Biophys. Res. Commun. 249: 811-816
13. Lavista-Llanos S., Centanin L., Irisarri M., Russo D. M., Gleadle J. M., Bocca S. N. et al. (2002) Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar. Mol. Cell. Biol. 22: 6842-6853
14. Soitamo A. J., Rabergh C. M., Gassmann M., Sistonen L. and Nikinmaa M. (2001) Characterization of a hypoxia-inducible factor (HIF-1 alpha) from rainbow trout. Accumulation of protein occurs at normal venous oxygen tension. J. Biol. Chem. 276: 19699-19705
15. Powell W. H. and Hahn M. E. (2002) Identification and functional characterization of hypoxia-inducible factor 2alpha from the estuarine teleost, Fundulus heteroclitus: interaction of HIF-2alpha with two ARNT2 splice variants. J. Exp. Zool. 249: 17-29
16. Gradin K, McGuire J., Wenger R. H., Kvietikova I., Whitelaw M. L., Toftgåard R. et al. (1996) Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16: 5221-5231
17. Chan W. K., Yao G., Gu Y. Z. and Bradfield C. A. (1999) Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J. Biol. Chem. 274: 12115-12123
18. Pollenz R. S., Davarinos N. A. and Shearer T. P. (1999) Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol. Pharmacol. 56: 1127-1137
19. Antonsson C., Whitelaw M. L., McGuire J., Gustafsson J. A. and Poellinger L. (1995) Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains. Mol. Cell. Biol. 15: 756-765
20. Coumailleau P., Poellinger L., Gustafsson J. A. and Whitelaw M. L. (1995) Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J. Biol. Chem. 270: 25291-25300
21. Minet E., Mottet D., Michel G., Roland I., Raes M., Remacle J. et al. (1999) Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 460: 251-256
22. Katschinski D. M., Le L., Heinrich D., Wagner K. F., Hofer T., Schindler S. G. et al. (2002) Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J. Biol. Chem. 277: 9262-9267
23. Isaacs J. S., Jung Y. J., Mimnaugh E. G., Martinez A., Cuttitta F. and Neckers L. M. (2002) Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1alpha-degradative pathway. J. Biol. Chem. 277: 29936-29944
24. Tian H., McKnight S. L. and Russell D. W. (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11: 72-82
25. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y. and Fujii-Kuriyama Y. (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 94: 4273-4278
26. Flamme I., Frohlich T., von Reutern M, Kappel A., Damert A. and Risau W. (1997) HRF, a putative basic helix-loop-helix-PAS-domain transcription factor, is closely related to hypoxiainducible factor-1 alpha and developmentally expressed in blood vessels. Mech. Dev. 63: 51-60
27. Hogenesch J. B., Gu Y. Z., Jain S. and Bradfield C. A. (1998) The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc. Natl. Acad. Sci. USA 95: 5474-5479
28. Jiang B. H., Rue E., Wang G. L., Roe R. and Semenza G. L. (1996) Dimerization, DNA binding and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271: 17771-17778
29. Jiang B. H., Zheng J. Z., Leung S. W., Roe R. and Semenza G. L. (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272: 19253-19260
30. Pugh C. W., O'Rourke J. F., Nagao M., Gleadle J. M. and Ratcliffe P. J. (1997) Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J. Biol. Chem. 272: 11205-11214
31. O'Rourke J. F., Tian Y. M., Ratcliffe P. J. and Pugh C. W. (1999) Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J. Biol. Chem. 274: 2060-2071
32. Wenger R. H., Kvietikova I., Rolfs A., Gassmann M. and Marti H. H. (1997) Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int. 51: 560-563
33. Wiesener M. S., Turley H., Allen W. E., Willam C., Eckardt K. U., Talks K. L. et al. (1998) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92: 2260-2268
34. Talks K. L., Turley H., Gatter K. C., Maxwell P. H., Pugh C. W., Ratcliffe P. J. et al. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers and tumor-associated macrophages. Am. J. Pathol. 157: 411-421
35. Gu Y. Z., Moran S. M., Hogenesch J. B., Wartman L. and Bradfield C. A. (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr. 7: 205-213
36. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H. et al. (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414: 550-554
37. Makino Y., Kanopka A., Wilson W. J., Tanaka H. and Poellinger L. (2002) Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J. Biol. Chem. 277: 32405-32408
38. Wenger R. H., Rolfs A., Kvietikova I., Spielmann P., Zimmermann D. R. and Gassmann M. (1997) The mouse gene for hypoxia-inducible factor-1alpha - genomic organization, expression and characterization of an alternative first exon and 5′ flanking sequence. Eur. J. Biochem. 246: 155-165
39. Wenger R. H., Rolfs A., Spielmann P., Zimmermann D. R. and Gassmann M. (1998) Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91: 3471-3480
40. Gorlach A., Camenisch G., Kvietikova I., Vogt L., Wenger R. H. and Gassmann M. (2000) Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions [In Process Citation]. Biochim. Biophys. Acta 1493: 125-134
41. Marti H. H., Katschinski D. M., Wagner K. F., Schaffer L., Stier B. and Wenger R. H. (2002) Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Mol. Endocrinol. 16: 234-243
42. Lukashev D., Caldwell C., Ohta A., Chen P. and Sitkovsky M. (2001) Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J. Biol. Chem. 276: 48754-48763
43. Gothie E., Richard D. E., Berra E., Pages G. and Pouyssegur J. (2000) Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha. J. Biol. Chem. 275: 6922-6927
44. Chun Y. S., Choi E., Kim T. Y., Kim M. S. and Park J. W. (2002) A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene. Biochem. J. 362: 71-79
45. Chun Y. S., Choi E., Kim G. T., Lee M. J., Lee S. E., Kim M. S. et al. (2000) Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1alpha, but inhibits the nuclear translocation of HIF-1beta, causing HIF-1 inactivation. Biochem. Biophys. Res. Commun. 268: 652-656
46. Thrash-Bingham C. A. and Tartof K. D. (1999) aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl. Cancer Inst. 91: 143-151
47. Yu A. Y., Frid M. G., Shimoda L. A., Wiener C. M., Stenmark K. and Semenza G. L. (1998) Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am. J. Physiol. 275: L818-L826
48. Huang L. E., Gu J., Schau M. and Bunn H. F. (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95: 7987-7992
49. Huang L. E., Arany Z., Livingston D. M. and Bunn H. F. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271: 32253-32259
50. Powell J. D., Elshtein R., Forest D. J. and Palladino M. A. (2002) Stimulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein in the adult rat testis following ischemic injury occurs without an increase in HIF-1alpha messenger RNA expression. Biol. Reprod. 67: 995-1002
51. Kallio P. J., Pongratz I., Gradin K., McGuire J. and Poellinger L. (1997) Activation of hypoxia-inducible factor 1alpha: post-transcriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA 94: 5667-5672
52. Kallio P. J., Wilson W. J., O'Brien S., Makino Y. and Poellinger L. (1999) Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274: 6519-6525
53. Sutter C. H., Laughner E. and Semenza G. L. (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97: 4748-4753
54. Cho S., Choi Y. J., Kim J. M., Jeong S. T., Kim J. H., Kim S. H. et al. (2001) Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMAT. FEBS Lett. 498: 62-66
55. Lisztwan J., Imbert G., Wirbelauer C., Gstaiger M. and Krek W. (1999) The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13: 1822-1833
56. Iliopoulos O., Levy A. P., Jiang C., Kaelin W. Jr and Goldberg M. A. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93: 10595-10599
57. Gnarra J. R., Zhou S., Merrill M. J., Wagner J. R., Krumm A., Papavassiliou E. et al. (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93: 10589-10594
58. Maxwell P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E. et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275
59. Cockman M. E., Masson N., Mole D. R., Jaakkola P., Chang G. W., Clifford S. C. et al. (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275: 25733-25741
60. Ohh M., Park C. W., Ivan M., Hoffman M. A., Kim T. Y., Huang L. E. et al. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2: 423-427
61. Tanimoto K., Makino Y., Pereira T. and Poellinger L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau minor suppressor protein. EMBO J. 19:, 4298-4309
62. Masson N., Willam C., Maxwell P. H., Pugh C. W. and Ratcliffe P. J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20: 5197-5206
63. Srinivas V., Zhang L. P., Zhu X. H. and Caro J. (1999) Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins. Biochem. Biophys. Res. Commun. 260: 557-561
64. Ohh M., Yauch R. L., Lonergan K. M., Whaley J. M., Stemmer-Rachamimov A. O., Louis D. N. et al. (1998) The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell. 1: 959-968
65. Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J. et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472
66. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M. et al. (2001) HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464-468
67. Yu F., White S. B., Zhao Q. and Lee F. S. (2001) HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98: 9630-9635
68. Chan D. A., Sutphin P. D., Denko N. C. and Giaccia A. J. (2002) Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 16: 16
69. Min J. H., Yang H., Ivan M., Gertler F., Kaelin W. G. Jr and Pavletich N. P. (2002) Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296: 1886-1889
70. Bruick R. K. and McKnight S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIE. Science 294: 1337-1340
71. Epstein A. C., Gleadle J. M., McNeill L. A., Hewitson K. S., O'Rourke J., Mole D. R. et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54
72. Ivan M., Haberberger T., Gervasi D. C., Michelson K. S., Gunzler V., Kondo K. et al. (2002) Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99: 13459-13464
73. Lieb M. E., Menzies K., Moschella M. C., Ni R. and Taubman M. B. (2002) Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem. Cell. Biol. 80: 421-426
74. Huang J., Zhao Q., Mooney S. M. and Lee F. S. (2002) Sequence determinants in hypoxia inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2 and PHD3. J. Biol. Chem. 13: 13
75. Oehme F., Ellinghaus P., Kolkhof P., Smith T., Ramakrishnan S., Hutter J. et al. (2002) Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296: 343
76. Kivirikko K. I. and Myllyharju J. (1998) Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 16: 357-368
77. Berra E., Richard D. E., Gothie E. and Pouyssegur J. (2001) HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation. FEBS Lett. 491: 85-90
78. An W. G., Kanekal M., Simon M. C., Maltepe E., Blagosklonny M. V. and Neckers L. M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408
79. Hansson L. O., Friedler A., Freund S., Rudiger S. and Fersht A. R. (2002) Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc. Natl. Acad. Sci. USA 99: 10305-10309
80. Suzuki H., Tomida A. and Tsuruo T. (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20: 5779-5788
81. Ravi R., Mookerjee B., Bhujwalla Z. M., Sutter C. H., Artemov D., Zeng Q. et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14: 34-44
82. Bae M. K., Ahn M. Y., Jeong J. W., Bae M. H., Lee Y. M., Bae S. K. et al. (2002) Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 277: 9-12
83. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K. et al. (1999) Molecular mechanisms of transcription activation by HLF and HIF 1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18: 1905-1914
84. Kallio P. J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H. et al. (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J. 17: 6573-6586
85. Ebert B. L. and Bunn H. F. (1998) Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor and p300/CREB binding protein. Mol. Cell. Biol. 18: 4089-4096
86. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H. and Poellinger L. (2000) Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 20: 402-415
87. Gu J., Milligan J. and Huang L. E. (2001) Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine. J. Biol. Chem. 276: 3550-3554
88. Kobayashi A., Numayama-Tsuruta K, Sogawa K. and Fujii-Kuriyama Y. (1997) CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. 122: 703-710
89. Lando D., Pongratz I., Poellinger L. and Whitelaw M. L. (2000) A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J. Biol. Chem. 275: 4618-4627
90. Freedman S. J., Sun Z. Y., Poy F., Kung A. L., Livingston D. M., Wagner G. et al. (2002) Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. USA 99: 5367-5372
91. Dames S. A., Martinez-Yamout M., De Guzman R. N., Dyson H. J. and Wright P. E. (2002) Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. USA 99: 5271-5276
92. Ruas J. L., Poellinger L. and Pereira T. (2002) Functional analysis of hypoxia-inducible factor-1 alpha-mediated transactivation. Identification of amino acid residues critical for transcriptional activation and/or interaction with CREB-binding protein. J. Biol. Chem. 277: 38723-38730
93. Bhattacharya S., Michels C. L., Leung M. K., Arany Z. P., Kung A. L. and Livingston D. M. (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13: 64-75
94. Yin Z., Haynie J., Yang X., Han B., Kiatchoosakun S., Restivo J. et al. (2002) The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc. Natl. Acad. Sci. USA 99: 10488-10493
95. Lando D., Peet D. J., Whelan D. A., Gorman J. J. and Whitelaw M. L. (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861
96. Sang N., Fang J., Srinivas V., Leshchinsky I. and Caro J. (2002) Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by avon Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBE Mol. Cell. Biol. 22: 2984-2992
97. Mahon P. C., Hirota K. and Semenza G. L. (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15: 2675-2686
98. Lando D., Peet D. J., Gorman J. J., Whelan D. A., Whitelaw M. L. and Bruick R. K. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16: 1466-1471
99. Hewitson K. S., McNeill L. A., Riordan M. V., Tian Y. M., Bullock A. N., Welford R. W. et al. (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277: 26351-26355
100. Stenflo J., Holme E., Lindstedt S., Chandramouli N., Huang L. H., Tam J. P, et al. (1989) Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase. Proc. Natl. Acad. Sci. USA 86: 444-447
101. Wang Q. P., VanDusen W. J., Petroski C. J., Garsky V. M., Stern A. M. and Friedman P. A. (1991) Bovine liver aspartyl beta-hydroxylase. Purification and characterization. J. Biol. Chem. 266: 14004-14010
102. McNeill L. A., Hewitson K. S., Gleadle J. M., Horsfall L. E., Oldham N. J., Maxwell P. H. et al. (2002) The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg. Med. Chem. Lett. 12: 1547-1550
103. Maranchie J. K., Vasselli J. R., Riss J., Bonifacino J. S., Linehan W. M. and Klausner R. D. (2002) The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1: 247-255
104. Kondo K, Klco J., Nakamura E., Lechpammer M. and Kaelin W. G. Jr (2002) Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1: 237-246
105. Willam C., Masson N., Tian Y. M., Mahmood S. A., Wilson M. I., Bicknell R. et al. (2002) Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc. Natl. Acad. Sci. USA 99: 10423-10428
106. Stroka D. M., Burkhardt T., Desbaillets I., Wenger R. H., Neil D. A., Bauer C. et al. (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J. 15: 2445-2453
107. Zelzer E., Levy Y., Kahana C., Shilo B. Z., Rubinstein M. and Cohen B. (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 17: 5085-5094
108. Fukuda R., Hirota K., Fan F., Jung Y. D., Ellis L. M. and Semenza G. L. (2002) IGF-1 induces HIF-1-mediated VEGF expression that is dependent on MAP kinase and PI-3-kinase signaling in colon cancer cells. J. Biol. Chem. 30: 30
109. Stiehl D. P., Jelkmann W., Wenger R. H. and Hellwig-Burgel T. (2002) Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett, 512: 157-162
110. Feldser D., Agani F., Iyer N. V., Pak B., Ferreira G. and Semenza G. L. (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59: 3915-3918
111. Gorlach A., Diebold I., Schini-Kerth V. B., Berchner-Pfannschmidt U., Roth U., Brandes R. P. et al. (2001) Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89: 47-54
112. Richard D. E., Berra E. and Pouyssegur J. (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275: 26765-26771
113. Tacchini L., Dansi P., Matteucci E. and Desiderio M. A. (2001) Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22: 1363-1371
114. Thornton R. D., Lane P., Borghaei R. C., Pease E. A., Caro J. and Mochan E. (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350: 307-312
115. Haddad J. J. and Land S. C. (2001) A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505: 269-274
116. Hellwig-Burgel T., Rutkowski K., Metzen E., Fandrey J. and Jelkmann W. (1999) Interleukin-1 beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561-1567
117. Haddad J. J. (2002) Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1alpha (HIF-1alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur. Cytokine Netw. 13: 250-260
118. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F. et al. (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-197
119. Kimura H., Ogura T., Kurashima Y., Weisz A. and Esumi H. (2002) Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem. Biophys. Res. Commun. 296: 976
120. Sandau K. B., Faus H. G. and Brune B. (2000) Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 278: 263-267
121. Sandau K. B., Zhou J., Kietzmann T. and Brune B. (2001) Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276: 39805-39811
122. Sandau K. B., Fandrey J. and Brune B. (2001) Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 97: 1009-1015
123. Palmer L. A., Gaston B. and Johns R. A. (2000) Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharmacol. 58: 1197-1203
124. Liu Y., Christou H., Morita T., Laughner E., Semenza G. L. and Kourembanas S. (1998) Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J. Biol. Chem. 273: 15257-15262
125. Huang L. E., Willmore W. G., Gu J., Goldberg M. A. and Bunn H. F. (1999) Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 274: 9038-9044
126. Agani F. H., Puchowicz M., Chavez J. C., Pichiule P. and LaManna J. (2002) Role of nitric oxide in the regulation of HIF-1alpha expression during hypoxia. Am. J. Physiol. Cell. Physiol. 283: C178-C186
127. Wang F., Sekine H., Kikuchi Y., Takasaki C., Miura C., Heiwa O. et al. (2002) HIF-1alpha-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway. Biochem. Biophys. Res. Commun. 295: 657-662
128. Chandel N. S., McClintock D. S., Feliciano C. E., Wood T. M., Melendez J. A., Rodriguez A. M. et al. (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275: 25130-25138
129. Gao N., Ding M., Zheng J. Z., Zhang Z., Leonard S. S., Liu K. J. et al. (2002) Vanadate-induced expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277: 31963-31971
130. Wang G. L., Jiang B. H. and Semenza G. L. (1995) Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 212: 550-556
131. Wang G. L., Jiang B. H. and Semenza G. L. (1995) Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216: 669-675
132. Gradin K., Takasaki C., Fujii-Kuriyama Y. and Sogawa K. (2002) The transcriptional activation function of the HIF-like factor requires phosphorylation at a conserved threonine. J. Biol. Chem. 277: 23508-23514
133. Sodhi A., Montaner S., Patel V., Zohar M., Bais C., Mesri E. A. et al. (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res. 60: 4873-4880
134. Agani F. and Semenza G. L. (1998) Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol. Pharmacol. 54: 749-754
135. Conrad P. W., Freeman T. L., Beitner-Johnson D. and Millhorn D. E. (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J. Biol. Chem 274: 33709-33713
136. Hur E., Chang K. Y., Lee E., Lee S. K. and Park H. (2001) Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol. Pharmacol. 59: 1216-1224
137. Hofer T., Desbaillets I., Hopfl G., Gassmann M. and Wenger R. H. (2001) Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy. FASEB J. 15: 2715-2717
138. Miner E., Arnould T., Michel G., Roland I., Mottet D., Raes M. et al. (2000) ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett. 468: 53-58
139. Minet E., Michel G., Mottet D., Raes M. and Michiels C. (2001) Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic. Biol. Med. 31: 847-855
140. Richard D. E., Berra E., Gothie E., Roux D. and Pouyssegur J. (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274: 32631-32637
141. Laughner E., Taghavi P., Chiles K., Mahon P. C. and Semenza G. L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21: 3995-4004
142. Treins C., Giorgetti-Peraldi S., Murdaca J., Semenza G. L. and Van Obberghen E. (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277: 27975-27981
143. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M. M. et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60: 1541-1545
144. Kim C. H., Cho Y. S., Chun Y. S., Park J. W. and Kim M. S. (2002) Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ. Res. 90: E25-E33
145. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E. et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14: 391-396
146. Arsham A. M., Plas D. R., Thompson C. B. and Simon M. C. (2002) Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277: 15162-15170
147. Hirota K. and Semenza G. L. (2001) Rac 1 activity is required for the activation of hypoxia-inducible factor 1. J. Biol. Chem. 276: 21166-21172
148. Aragones J., Jones D. R., Martin S., San Juan M. A., Alfranca A., Vidal F. et al. (2001) Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J. Biol. Chem. 276: 10548-10555
149. Karni R., Dor Y., Keshet E., Meyuhas O. and Levitzki A. (2002) Activated pp60c-Src leads to elevated HIF-1 alpha expression under normoxia. J. Biol. Chem. 27: 27
150. Chilov D., Camenisch G., Kvietikova I., Ziegler U., Gassmann M. and Wenger R. H. (1999) Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J. Cell Sci. 112: 1203-1212
151. Groulx I. and Lee S. (2002) Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol. 22: 5319-5336
152. Berra E., Roux D., Richard D. E. and Pouyssegur J. (2001) Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2: 615-620
153. Fatyol K. and Szalay A. A. (2001) The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J. Biol. Chem. 276: 28421-28429
154. Mukhopadhyay C. K., Mazumder B. and Fox P. L. (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275: 21048-21054
155. Wang G. L. and Semenza G. L. (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82: 3610-3615
156. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K. I., Miller M. P. et al. (1999) Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin. J. Neurosci. 19: 9821-9830
157. Rolfs A., Kvietikova I., Gassmann M. and Wenger R. H. (1997) Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272: 20055-20062
158. Lok C. N. and Ponka P. (1999) Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274: 24147-24152
159. Bianchi L., Tacchini L. and Cairo G. (1999) HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res. 27: 4223-4227
160. Tacchini L., Bianchi L., Bernelli-Zazzera A. and Cairo G. (1999) Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274: 24142-24146
161. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D. et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16: 4604-4613
162. Levy A. P., Levy N. S., Wegner S. and Goldberg M. A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270: 13333-13340
163. Liu Y., Cox S. R., Morita T. and Kourembanas S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77: 638-643
164. Grosfeld A., Turban S., Andre J., Cauzac M., Challier J. C., Hauguel-de Mouzon S. et al. (2001) Transcriptional effect of hypoxia on placental leptin. FEBS Lett. 502: 122-126
165. Ambrosini G., Nath A. K., Sierra-Honigmann M. R. and Flores-Riveros J. (2002) Transcriptional activation of the human leptin gene in response to hypoxia: involvement of hypoxia-inducible factor 1. J. Biol. Chem. 25: 25
166. Hu J., Discher D. J., Bishopric N. H. and Webster K. A. (1998) Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245: 894-899
167. Yamashita K., Discher D. J., Hu J., Bishopric N. H. and Webster K. A. (2001) Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2 and p300/CBP. J. Biol. Chem. 276: 12645-12653
168. Minchenko A. and Caro J. (2000) Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol. Cell. Biochem. 208: 53-62
169. Gerber H. P., Condorelli F., Park J. and Ferrara N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272: 23659-23667
170. Kietzmann T., Roth U. and Jungermann K. (1999) Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94: 4177-4185
171. Samoylenko A., Roth U., Jungermann K. and Kietzmann T. (2001) The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. Blood 97: 2657-2666
172. Melillo G., Musso T., Sica A., Taylor L. S., Cox G. W. and Varesio L. (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:, 1683-1693
173. Palmer L. A., Semenza G. L., Stoler M. H. and Johns R. A. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274: L212-L219
174. Furuta G. T., Turner J. R., Taylor C. T., Hershberg R. M., Comerford K., Narravula S. et al. (2001) Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193: 1027-1034
175. Lee P. J., Jiang B. H., Chin B. Y., Iyer N. V., Alam J., Semenza G. L. et al. (1997) Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272: 5375-5381
176. Cormier-Regard S., Nguyen S. V. and Claycomb W. C. (1998) Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273: 17787-17792
177. Nguyen S. V. and Claycomb W. C. (1999) Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem. Biophys. Res. Commun. 265: 382-386
178. Eckhart A. D., Yang N., Xin X. and Faber J. E. (1997) Characterization of the alpha 1 B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 94: 9487-992
179. Ebert B. L., Firth J. D. and Ratcliffe P. J. (1995) Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270: 29083-29089
180. Chen C., Pore N., Behrooz A., Ismail-Beigi F. and Maity A. (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 276: 9519-9525
181. Semenza G. L., Roth P. H., Fang H. M. and Wang G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269: 23757-23763
182. Semenza G. L., Jiang B. H., Leung S. W., Passantino R., Concordet J. P., Maire P. et al. (1996) Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271: 32529-32537
183. Firth J. D., Ebert B. L. and Ratcliffe P. J. (1995) Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270: 21021-21027
184. Graven K. K., Yu Q., Pan D., Roncarati J. S. and Farber H. W. (1999) Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim. Biophys. Acta 1447: 208-218
185. Minchenko A., Leshchinsky I., Opentanova I., Sang N., Srinivas V., Armstead V. et al. (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J. Biol. Chem. 277: 6183-6187
186. Mathupala S. P., Rempel A. and Pedersen P. L. (2001) Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J. Biol. Chem. 276: 43407-43412
187. Riddle S. R., Ahmad A., Ahmad S., Deeb S. S., Malkki M., Schneider B. K. et al. (2000) Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L407-L416
188. O'Rourke J. F., Pugh C. W., Bartlett S. M. and Ratcliffe P. J. (1996) Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur. J. Biochem. 241: 403-410
189. Wykoff C. C., Beasley N. J., Watson P. H., Turner K. J., Pastorek J., Sibtain A. et al. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60: 7075-7083
190. Estes S. D., Stoler D. L. and Anderson G. R. (1995) Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor. J. Virol. 69: 6335-6341
191. Tazuke S. I., Mazure N. M., Sugawara J., Carland G., Faessen G. H., Suen L. F. et al. (1998) Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. USA 95: 10188-10193
192. Oikawa M., Abe M., Kurosawa H., Hida W., Shirato K. and Sato Y. (2001) Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 289: 39-43
193. Bruick R. K. (2000) Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA 97: 9082-9087
194. Guo K., Searfoss G., Krolikowski D., Pagnoni M., Franks C., Clark K. et al. (2001) Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ. 8: 367-376
195. Sowter H. M., Ratcliffe P. J., Watson P., Greenberg A. H. and Harris A. L. (2001) HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61: 6669-6673
196. Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H. and Kato Y. (2002) Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 Genes. J. Biol. Chem. 277: 47014-47021
197. Takahashi Y., Takahashi S., Shiga Y., Yoshimi T. and Miura T. (2000) Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J. Biol. Chem. 275: 14139-14146
198. Norris M. L. and Millhorn D. E. (1995) Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene. J. Biol. Chem. 270: 23774-23779
199. Scheid A., Wenger R. H., Schaffer L., Camenisch I., Distler O., Ferenc A. et al. (2002) Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3. FASEB J. 16: 411-413
200. Bazan N. G. and Lukiw W. J. (2002) Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1 beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J. Biol. Chem. 277: 30359-30367
201. Lukiw W. J., Gordon W. C., Rogaev E. I., Thompson H. and Bazan N. G. (2001) Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis. Neuroreport 12: 53-57
202. Kvietikova I., Wenger R. H., Marti H. H. and Gassmann M. (1995) The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 23: 4542-4550
203. Michel G., Minet E., Ernest I., Roland I., Durant F., Remacle J. et al. (2000) A model for the complex between the hypoxia-inducible factor-1 (HIF-1) and its consensus DNA sequence [In Process Citation]. J. Biomol. Struct. Dyn. 18: 169-179
204. Wenger R. H., Kvietikova I., Rolfs A., Camenisch G. and Gassmann M. (1998) Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur. J. Biochem. 253: 771-777
205. Yun Z., Maecker H. L., Johnson R. S. and Giaccia A. J. (2002) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2: 331-341
206. Kojima H., Gu H., Nomura S., Caldwell C. C., Kobata T., Carmeliet P. et al. (2002) Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha-deficient chimeric mice. Proc. Natl. Acad. Sci. USA 99: 2170-2174
207. Kline D. D., Peng Y. J., Manalo D. J., Semenza G. L. and Prabhakar N. R. (2002) Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha. Proc. Natl. Acad. Sci. USA 99: 821-826
208. Akeno N., Czyzyk-Krzeska M. F., Gross T. S. and Clemens T. L. (2001) Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology 1421: 959-962
209. Elvert G., Lanz S, Kappel A. and Flamme I. (1999) mRNA cloning and expression studies of the quail homologue of HIF-2alpha. Mech. Dev. 87: 193-197
210. Compernolle V., Brusselmans K., Acker T., Hoet P., Tjwa M., Beck H. et al. (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8: 702-710
211. Camenisch G., Stroka D. M., Gassmann M. and Wenger R. H. (2001) Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Pflugers Arch. 443: 240-249
212. Sanchez-Elsner T., Botella L. M., Velasco B., Corbi A., Attisano L. and Bernabeu C. (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276: 38527-38535
213. Zhang W., Tsuchiya T. and Yasukochi Y. (1999) Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J. Hum. Genet. 44: 293-299
214. Kvietikova I., Wenger R. H., Marti H. H. and Gassmann M. (1997) The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 51: 564-566
215. Damert A., Ikeda E. and Risau W. (1997) Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J. 327: 419-423
216. Alfranca A., Gutierrez M. D., Vara A, Aragones J., Vidal F. and Landazuri M. O. (2002) c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell. Biol. 22: 12-22
217. Iyer N. V., Kotch L. E., Agani F., Leung S. W., Laughner E., Wenger R. H. et al. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12: 149-162
218. Kotch L. E., Iyer N. V., Laughner E. and Semenza G. L. (1999) Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. 209: 254-267
219. Yu A. Y., Shimoda L. A., Iyer N. V., Huso D. L., Sun X., McWilliams R. et al. (1999) Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J. Clin. Invest. 103: 691-696
220. Schipani E., Ryan H. E., Didrickson S., Kobayashi T., Knight M. and Johnson R. S. (2001) Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15: 2865-2876
221. Peng J., Zhang L., Drysdale L. and Fong G. H. (2000) The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA 97: 8386-8391
222. Tian H., Hammer R. E., Matsumoto A. M., Russell D. W. and McKnight S. L. (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12: 3320-3324
223. Brusselmans K., Bono F., Maxwell P., Dor Y., Dewerchin M., Collen D. et al. (2001) Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J. Biol. Chem. 276: 39192-39196
224. Carmeliet P., Dor Y., Herbert J. M., Fukumura D., Brusselmans K., Dewerchin M. et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490
225. Blancher C., Moore J. W., Robertson N. and Harris A. L. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61: 7349-7355
226. Seagroves T. N., Ryan H. E., Lu H., Wouters B. G., Knapp M., Thibault P. et al. (2001) Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21: 3436-3444
227. Lu H., Forbes R. A. and Verma A. (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277: 23111-23115
228. Jiang B. H., Agani F., Passaniti A. and Semenza G. L. (1997) V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 57: 5328-5335
229. Mazure N. M., Chen E. Y., Laderoute K. R. and Giaccia A. J. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90: 3322-3331
230. Xia G., Kageyama Y., Hayashi T., Hyochi N., Kawakami S. and Kihara K. (2002) Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancen. Urology 59: 774-778
231. Zagzag D., Friedlander D. R., Margolis B., Grumet M., Semenza G. L., Zhong H. et al. (2000) Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr. Neurosurg. 33: 49-55
232. Birner P., Gatterbauer B., Oberhuber G., Schindl M., Rossler K., Prodinger A. et al. (2001) Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92: 165-171
233. Leek R. D., Talks K. L., Pezzella F., Turley H., Campo L., Brown N. S. et al. (2002) Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in rumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res. 62: 1326-1329
234. Bos R., Zhong H., Hanrahan C. F., Mommers E. C., Semenza G. L., Pinedo H. M. et al. (2001) Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93: 309-314
235. Birner P., Schindl M., Obermair A., Plank C., Breitenecker G. and Oberhuber G. (2000) Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60: 4693-4696
236. Giatromanolaki A., Koukourakis M. I., Sivridis E., Turley H., Talks K., Pezzella F. et al. (2001) Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer 85: 881-890
237. Stewart M., Talks K., Leek R., Turley H., Pezzella F., Harris A. et al. (2002) Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 40: 253-260
238. Koukourakis M. I., Giatromanolaki A., Skarlatos J., Corti L., Blandamura S., Piazza M. et al. (2001) Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61: 1830-1832
239. Aebersold D. M., Burri P., Beer K. T., Laissue J., Djonov V., Greiner R. H. et al. (2001) Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61: 2911-2916
240. Akakura N., Kobayashi M., Horiuchi I., Suzuki A., Wang J., Chen J. et al. (2001) Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61: 6548-6554
241. Zhong H., De Marzo A. M., Laughner E., Lim M., Hilton D. A., Zagzag D. et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59: 5830-5835
242. Ryan H. E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J. M. et al. (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60: 4010-4015
243. Ryan H. E., Lo J. and Johnson R. S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17: 3005-3015
244. Maxwell P. H., Dachs G. U., Gleadle J. M., Nicholls L. G., Harris A. L., Stratford I. J. et al. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94: 8104-8109
245. Birner P., Schindl M., Obermair A., Breitenecker G. and Oberhuber G. (2001) Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 7: 1661-1668
246. Couch V., Lindor N. M., Karnes P. S. and Michels V. V. (2000) von Hippel-Lindau disease. Mayo Clin. Proc. 75: 265-272
247. Maher E. R. and Kaelin W. G. Jr (1997) von Hippel-Lindau disease. Medicine 76: 381-391
248. Krek W. (2000) VHL takes HIF's breath away. Nat. Cell Biol. 2: E121-E123
249. Hoffman M. A., Ohh M., Yang H., Klco J. M., Ivan M. and Kaelin W. G. Jr (2001) von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to down-regulate HIF. Hum. Mol. Genet. 10: 1019-1027
250. Zhou M. I., Wang H., Ross J. J., Kuzmin I., Xu C. and Cohen H. T. (2002) The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. J. Biol. Chem. 277: 39887-39898
251. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S. J., Kuliszewski M. et al. (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J. Clin. Invest. 105: 577-587
252. Adelman D. M., Gertsenstein M., Nagy A., Simon M. C. and Maltepe E. (2000) Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 14: 3191-3203
253. Martin C., Yu A. Y., Jiang B. H., Davis L., Kimberly D., Hohimer A. R. et al. (1998) Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178: 527-534
254. Bergeron M., Yu A. Y., Solway K. E., Semenza G. L. and Sharp F. R. (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11: 4159-4170
255. Lee S. H., Wolf P. L., Escudero R., Deutsch R., Jamieson S. W. and Thistlethwaite P. A. (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342: 626-633
256. Li J., Post M., Volk R., Gao Y., Li M., Metais C. et al. (2000) PR39, a peptide regulator of angiogenesis. Nat. Med. 6: 49-55
257. Elson D. A., Thurston G., Huang L. E., Ginzinger D. G., McDonald D. M., Johnson R. S. et al. (2001) Induction of hyper-vascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha, Genes Dev. 15: 2520-2532
258. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K. et al. (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 28: 131-138
259. Kung A. L., Wang S., Klco J. M., Kaelin W. G. and Livingston D. M. (2000) Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6: 1335-1340
260. Rapisarda A., Uranchimeg B., Scudiero D. A., Selby M., Sausville E. A., Shoemaker R. H. et al. (2002) Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62: 4316-4324